Peptides for skin health
Skin is an organ that rebuilds itself constantly — collagen scaffolding, new cells, repair signals. These articles cover peptides for skin renewal and repair, like the copper peptide GHK-Cu, plus practical topics like hair shedding and what actually supports healthy skin from the inside.
The tone is evidence-first: what researchers have measured, and what's still unknown. Treatments mentioned here are compounded and prescription-only, with a licensed provider reviewing every request. Topical and injectable routes are different conversations, and the articles say which one the evidence covers.
11 articles on this topic
-
Does Sermorelin Cause Hair Loss? Evidence Review
Current evidence does not identify hair loss as a sermorelin side effect. Growth hormone and IGF-1 affect follicles, but that biology cannot explain why one person starts shedding.
-
KPV Peptide Benefits: What the Evidence Shows
KPV's strongest benefit signals are lower inflammatory activity in cultured cells and mouse colitis models. No human trial has established a KPV benefit, dose, or safety profile.
-
KLOW Peptide Benefits: What Each Component Adds
KLOW brings four peptide research rationales into one compounded formulation. The evidence runs from cell studies to animal models, but no clinical trial has tested the finished blend.
-
GHK-Cu Dosage: How Prescribers Set the Amount
There is no validated human injection dose for GHK-Cu. Topical studies disclose several concentrations, while compounded injection amounts come from clinical practice and must be tied to the exact vial and the person being treated.
-
KLOW vs GLOW: What KPV Adds to the Blend
KLOW and GLOW share BPC-157, TB-500, and GHK-Cu; KLOW adds KPV, an inflammation-focused tripeptide backed by cell and mouse studies—not blend-level human trials.
-
GHK-Cu Side Effects: Topical vs Injectable
GHK-Cu side effects are usually mild with topical cosmetics, but injectable GHK-Cu has no long-term human safety data. Route is the difference that matters.
-
Does Semaglutide Cause Hair Loss?
In the pooled 68-week trials, hair loss was reported by 3% of adults on semaglutide 2.4 mg against 1% on placebo. Telogen effluvium after fast weight loss explains it better than any proven effect on the follicle.
-
Does Tirzepatide Cause Hair Loss?
In the pivotal 72-week obesity trials, hair loss was reported by about 3%–7% of tirzepatide groups versus about 1% with placebo. Weight-loss-related telogen effluvium is the leading explanation, but a direct drug effect has not been ruled out.
-
Inside the Glow Peptide Blend
Glow combines three peptides with non-overlapping jobs — BPC-157 signals new blood-vessel growth, TB-500 binds the cell-scaffolding protein actin, and GHK-Cu delivers copper to the enzyme that cross-links collagen.
-
Melanotan 2 Side Effects Beyond the Tan
Melanotan II's prospective human trial record is small; broader safety information comes mainly from case reports and seized vials.
-
GHK-Cu Benefits: The Copper Peptide, Explained
GHK-Cu benefits start from one well-documented fact: blood levels of this three-amino-acid copper peptide fall from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60.